Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture
- PMID: 10337661
Establishment and characterization of a serous papillary adenocarcinoma cell line of the human ovary in a serum-free culture
Abstract
In order to clarify the biologic characteristics of serous papillary adenocarcinoma of the human ovary, we tried to establish a continuous cell line using four primary tumor specimens derived from four patients with such tumors. We also evaluated c-myc, MYCN and c-erbB2 gene amplification in the cultured cells, and the xenografts, as well as in these four primary tissue specimens by a Southern blot analysis. One continuous cell line, named as FU-OV-1, was established in a serum-free culture system and this line propagated continuously for 96 serial passages over a 2-year-period in vitro. FU-OV-1 reproduced and still maintained the characteristics of the original tumor. C-myc gene amplification was found in the FU-OV-1 cells, and the xenografts, as well as in only the primary tumor of FU-OV-1 out of the four primary serous papillary adenocarcinomas. However, neither MYCN amplification nor c-erbB2 amplification was observed in any tumor specimens including FU-OV-1 cells. In conclusion, FU-OV-1 is thus considered to be a useful system for studying the biological behavior of serous papillary adenocarcinoma in the human ovary. The results of this study suggest that c-myc gene amplification might thus be associated with the progression of this tumor both in vitro and in vivo.
Similar articles
-
Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation.Gynecol Oncol. 2001 Dec;83(3):523-32. doi: 10.1006/gyno.2001.6425. Gynecol Oncol. 2001. PMID: 11733966
-
Establishment and characterization of human cell lines from a serous papillary adenocarcinoma of the endometrium.Gynecol Oncol. 1994 Aug;54(2):184-95. doi: 10.1006/gyno.1994.1191. Gynecol Oncol. 1994. PMID: 8063244
-
[The establishment of human ovarian carcinoma cell line HO-8910 and its characteristics].Zhonghua Fu Chan Ke Za Zhi. 1994 Mar;29(3):162-4, 191. Zhonghua Fu Chan Ke Za Zhi. 1994. PMID: 8082435 Chinese.
-
Characterization of a human ovarian carcinoma cell line: UCI 101.Gynecol Oncol. 1993 Feb;48(2):203-9. doi: 10.1006/gyno.1993.1034. Gynecol Oncol. 1993. PMID: 8428692
-
HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.Exp Mol Pathol. 1999 Jun;66(2):163-9. doi: 10.1006/exmp.1999.2255. Exp Mol Pathol. 1999. PMID: 10409445
Cited by
-
Establishment of a new cell line of endometrioid carcinoma of the ovary and its chemosensitivity.Hum Cell. 2007 Aug;20(3):71-6. doi: 10.1111/j.1749-0774.2007.00030.x. Hum Cell. 2007. PMID: 17645726
-
Ovarian cancer cell lines derived from non-serous carcinomas migrate and invade more aggressively than those derived from high-grade serous carcinomas.Sci Rep. 2019 Apr 2;9(1):5515. doi: 10.1038/s41598-019-41941-4. Sci Rep. 2019. PMID: 30940866 Free PMC article.
-
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.Mol Oncol. 2013 Jun;7(3):567-79. doi: 10.1016/j.molonc.2012.12.007. Epub 2013 Jan 31. Mol Oncol. 2013. PMID: 23415752 Free PMC article.
-
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines.Cell Rep. 2018 Nov 27;25(9):2617-2633. doi: 10.1016/j.celrep.2018.10.096. Cell Rep. 2018. PMID: 30485824 Free PMC article.
-
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies.Front Oncol. 2014 Mar 6;4:40. doi: 10.3389/fonc.2014.00040. eCollection 2014. Front Oncol. 2014. PMID: 24639951 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous